| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Butyrate | Atherosclerosis | 1 | PM | 36888629 | 📋 | Butyrate suppresses atherosclerotic inflammation by regulating macrophages and polarization via GPR43/HDAC-miRNAs axis in ApoE-/- mice |
| Butyrate | Diabetic Cardiomyopathy | 1 | PM | 36657710 | 📋 | Sodium butyrate and voluntary exercise through activating VEGF-A downstream signaling pathway improve heart angiogenesis in type 2 diabetes |
| Butyrate | Endothelial Dysfunction | 1 | PM | 37308032 | 📋 | Butyrate inhibits LPC-induced endothelial dysfunction by regulating nNOS-produced NO and ROS production |
| Butyrate | Hypertension | 1 | PM | 35623879 | 📋 | The effects of butyrate supplementation on glycemic control, lipid profile, blood pressure, nitric oxide level and glutathione peroxidase activity in type 2 diabetic patients: A randomized triple -blind, placebo-controlled trial |
| Butyrate | Ischemic Stroke | 1 | PM | 38486971 | 📋 | Protective effects of butyrate on cerebral ischaemic injury in animal models: a systematic review and meta-analysis |
| Butyrate | Myocardial Fibrosis | 1 | PM | 35662928 | 📋 | Butyric Acid Ameliorates Myocardial Fibrosis by Regulating M1/M2 Polarization of Macrophages and Promoting Recovery of Mitochondrial Function |
| Butyrate | Right Ventricular Hypertrophy | 1 | PM | 38176636 | 📋 | Sodium butyrate alleviates right ventricular hypertrophy in pulmonary arterial hypertension by inhibiting H19 and affecting the activation of let-7g-5p/IGF1 receptor/ERK |
